CDIO logo

CDIO Cardio Diagnostics Holdings, Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$2.21
+0.22 (+11.06%)

Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was establishe…

Market Cap: $6.54Mwww.cdio.ai

Price

No data yet.

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Revenue

$5.4K
$0.00$5.3K$10.6K$15.9K
Sep 2021Jun 2026

Analyst Estimates

FY2025
$-6.90
$-6.90$-6.90
1 analysts
FY2026
$-16.50
$-16.50$-16.50
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Meeshanthini V. Dogan
Sector
Healthcare
Industry
Biotechnology
Employees
15
Beta
2.22
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
-0.49
www.cdio.ai